Support for the hypothesis that successful immunotherapy of various cancers can be achieved by inhibiting a progesterone associated immunomodulatory protein

Medical Hypotheses

Volumn 72, Issue 1, 2009, Pages 87-90

  Check, J H ^a   Dix, E ^a   Sansoucie, L ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MIFEPRISTONE; MONOCLONAL ANTIBODY; PROGESTERONE; PROGESTERONE INDUCED BLOCKING FACTOR; PROGESTERONE RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER GROWTH; CANCER IMMUNOTHERAPY; CELL PROLIFERATION; CULTURE MEDIUM; CYTOLYSIS; HORMONE RELEASE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOSURVEILLANCE; IN VITRO STUDY; MALIGNANT NEOPLASTIC DISEASE; MURINE LEUKEMIA; NATURAL KILLER CELL; NEOPLASM; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; PROGESTERONE RELEASE; PROTEIN EXPRESSION; QUALITY OF LIFE; SOLID TUMOR; UPREGULATION;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; IMMUNOLOGIC FACTORS; IMMUNOTHERAPY; LUNG NEOPLASMS; MICE; MIFEPRISTONE; NEOPLASMS; PREGNANCY PROTEINS; PROGESTERONE; RECEPTORS, PROGESTERONE; RNA, MESSENGER; SUPPRESSOR FACTORS, IMMUNOLOGIC;

MAMMALIA; MURINAE;

EID: 56549089912     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2008.05.042     Document Type: Article

References (20)

1. Check J.H., Nazari P., Goldberg J., Yuen W., and Angotti D. A model for potential tumor immunotherapy based on knowledge of immune mechanisms responsible for spontaneous abortion. Med Hypoth 57 (2001) 337-343
2. Acevedo H.F., Tong J.Y., and Hartsock R.J. Human chorionic gonadotropin-beta subunit gene expression in cultured human fetal and cancer cells of different types and origins. Cancer 76 (1995) 1467-1475
3. Acevedo H.F., Longinotti S.M., and Marquardt M. Expression of hCG, its subunits and fragments by human cultured cancer cells of the nervous system. Cancer Detect Prevent 19 (1995) 37
4. Acevedo H.F., Campbell-Acevedo G.A., Buffo M.K., and Krichevsky A. In vivo expression of membrane-associated human chorionic gonadotropin by cells isolated from cancerous human tissues. Proc Am Assoc Cancer Res 34 (1994) 27
5. Szekeres-Bartho J., Varga P., and Pejtsik B. ELISA test for the detection of an immunological blocking factor in human pregnancy serum. J Reprod Immunol 16 (1989) 19-29
6. Szekeres-Bartho J., Faust Z., and Varga P. The expression of a progesterone-induced immunomodulatory protein in pregnancy lymphocytes. Am J Reprod Immunol 34 (1995) 342-348
7. Check J.H., Szekeres-Bartho J., and O'Shaughnessy A. Progesterone induced blocking factor seen in pregnancy lymphocytes soon after implantation. Am J Reprod Immunol 35 (1996) 277-280
8. Check J.H., Ostrzenski A., and Klimek R. Expression of an immunomodulatory protein known as progesterone induced blocking factor (PIBF) does not correlate with first trimester spontaneous abortions in progesterone supplemented women. Am J Reprod Immunol 37 (1997) 330-334
9. Szekeres-Bartho J., Barakonyi A., Polgar B., Par G., Faust Z., Palkovics T., et al. The role of gamma/delta T cells in progesterone-mediated immunomodulation during pregnancy: a review. Am J Reprod Immunol 42 (1999) 44-48
10. Szekeres-Bartho J., Kilar F., Falkay G., Csernus V., Torok A., and Pacsa A.S. The mechanism of the inhibitory effect of progesterone on lymphocyte cytotoxicity: I. Progesterone-treated lymphocytes release a substance inhibiting cytotoxicity and prostaglandin synthesis. Am J Reprod Microbiol 9 (1985) 15-18
11. Szekeres-Bartho J., Csernus V., and Hadnagy J. The blocking effect of progesterone on lymphocyte responsiveness is receptor-mediated. Biol Immunol Reprod 15 (1989) 36
12. Szekeres-Bartho J., Weill B.J., Mike G., Houssin D., and Chaouat G. Progesterone receptors in lymphocytes of liver-transplanted and transfused patients. Immunol Lett 22 (1989) 259-261
13. Chiu L., Nishimura M., Ishii Y., Nieda M., Maeshima M., Takedani Y., et al. Enhancement of the expression of progesterone receptor on progesterone treated lymphocyte after immunotherapy in unexplained recurrent spontaneous abortion. Am J Reprod Immunol 35 (1996) 552-557
14. Check J.H., Arwitz M., Gross J., Peymer M., and Szekeres-Bartho J. Lymphocyte immunotherapy (LI) increases serum levels of progesterone induced blocking factor. Am J Reprod Immunol 37 (1997) 17-20
15. Srivastave M.D., Thomas A., Srivastave B.I.S., and Check J.H. Expression and modulation of progesterone induced blocking factor (PIBF) and innate immune factors in human leukemia cell lines by progesterone and mifepristone. Leuk Lymph 48 8 (2007) 1610-1617
16. Check J.H., Sansoucie L., Chern J., Amadi N., and Katz Y. The effect of treatment with a progesterone receptor antagonist on death from spontaneous lymphocytic leukemia in AKR/J mice. Proc Am Assoc Cancer Res 47 (2006) 61
17. Check JH, SanSoucie L, Chern J, Dix E. Mifepristone treatment improves length and quality of survival of mice with spontaneous lung cancer. American Association for Cancer Research Annual Meeting, April 14-18, 2007, Los Angeles, California; 2007.
18. Check JH, Dix E, SanSoucie L, Amadi C, Check D, Brando K. Treatment with mifepristone improves the length and quality of life in mice with a strong predisposition to spontaneous testicular cancer. In: Proceedings of the 99th annual meeting of the American association for cancer research, April 12-16. San Diego, CA; 2008. Abstract No. 2154.
19. Dix E, Check JH, SanSoucie L, Check D, Amadi C. The effect of treatment with mifepristone on the length and quality of life of mice with a strong predisposition for prostate cancer. In: Proceedings of the 99th annual meeting of the American association for cancer research, April 12-16; San Diego, CA; 2008. Abstract No. 2155.
20. Check JH, SanSoucie L, Katsoff D, Katsoff B, Dix E. Mifepristone may halt progression of extensively metastatic human adenocarcinoma of the colon. American Association for Cancer Research Annual Meeting, April 14-18, 2007, Los Angeles, California; 2007.